As the search for a coronavirus vaccine continues, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is feeling "cautiously" optimistic.
"Given that the body can make a good response against coronavirus, we feel cautiously optimistic that if we mimic safely natural infection with our vaccine, we will be able to induce a response in a person that would be equivalent to the response that natural infection induces," Fauci explained on Tuesday, The Wall Street Journal reports.
Fauci, a member of President Trump's coronavirus task force, was optimistic that several COVID-19 vaccine candidates will be shown as effective in "a reasonable period of time" and pointed to the promising early data from Moderna, per the Journal, though he added that a major unanswered question is for how long any eventual vaccine might provide protection from the coronavirus.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"What is a big unknown is what the durability of that protection is," he said. "Is it going to be a year, two years or even maybe, unfortunately, six months or less?" If it provides protection for a fairly short period, he said this might lead to a "secondary problem" in trying to get enough doses out.
Speaking to the Journal of the American Medical Association, Fauci on Tuesday reiterated he's "cautiously optimistic" about getting a vaccine and pointed to the administration's hope of having a few hundred million doses available by the beginning of 2021, per CNN, though some experts have cast doubt on this incredibly tight timeline. But while he's feeling hopeful about the progress, Fauci also noted this week that there's "never a guarantee, ever, that you're going to get an effective vaccine."
-
Groypers: the alt-right group pulled into the foregroundThe Explainer The group is led by alt-right activist Nick Fuentes
-
10 concert tours to see this upcoming fallThe Week Recommends Get ready for pumpkin spice season with concerts from big-name artists
-
How to put student loan payments on pauseThe Explainer If you are starting to worry about missing payments, deferment and forbearance can help
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
